NCT03326713 Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project Status COMPLETED Phase NA
NCT03326674 Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC Status TERMINATED Phase PHASE3
NCT03324932 Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03321929 Intraoperative Detection of Residual Cancer in Breast Cancer Status COMPLETED Phase PHASE2
NCT03321045 Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness Status RECRUITING Phase EARLY_PHASE1
NCT03319069 Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer Status UNKNOWN Phase PHASE3
NCT03316794 A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC) Status TERMINATED Phase PHASE1
NCT03316586 A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer Status COMPLETED Phase PHASE2
NCT03314870 Development of a Response Signature to Neoadjuvant Chemotherapy for Breast Cancer Status UNKNOWN Phase NA
NCT03310541 AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations Status COMPLETED Phase PHASE1
NCT03308201 Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT03306472 A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer Status COMPLETED Phase PHASE2
NCT03304587 Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors Status COMPLETED Phase NA
NCT03304002 Implementation of a Web-based Decision Aid for Breast Cancer Surgery Status COMPLETED Phase N/A